<?xml version="1.0" encoding="UTF-8"?>
<p>In 33 out of 39 patients (84%) who consented to this subproject, granulocyte DNA was sequenced at study entry using a next-generation sequencing (NGS) panel of 94 genes (
 <xref rid="t3-1040710" ref-type="table">Table 3</xref>). In 10 out of 33 patients (30%), additional somatic mutations were detected (
 <xref rid="t3-1040710" ref-type="table">Table 3</xref>) and in 3 of these patients (9%) two concomitant mutations were present (
 <italic>TET2</italic> and 
 <italic>DNMT3A, PIAS2</italic> and 
 <italic>TYK2</italic>, 
 <italic>TP53</italic> and 
 <italic>PRPF40B</italic>). The presence or absence of additional mutations was not associated with clinical or laboratory parameters.
</p>
